Entera Bio (ENTX) Assets Average (2018 - 2026)

Entera Bio has disclosed Assets Average across 7 years of filings, most recently posting $14.6 million for Q1 2026.

• Quarterly Assets Average fell 6.03% year-over-year to $14.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.6 million (down 6.03% YoY) and the FY2025 annual result came in at $12.7 million, up 19.99% from the prior year.
• Assets Average retreated to $14.6 million in Q1 2026, from $16.7 million in the prior quarter.
• Over five years, Assets Average peaked at $24.1 million in Q1 2022 and troughed at $8.6 million in Q4 2024.
• A 5-year average of $14.4 million and a median of $14.3 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average tumbled 48.79% — and 2025, when it soared 108.56%.
• Tracing ENTX's Assets Average over 5 years: stood at $14.3 million in 2022, then decreased by 29.08% to $10.2 million in 2023, then decreased by 15.74% to $8.6 million in 2024, then surged by 94.97% to $16.7 million in 2025, then decreased by 12.81% to $14.6 million in 2026.
• Business Quant data shows ENTX's Assets Average at $14.6 million in Q1 2026, $16.7 million in Q4 2025, and $18.5 million in Q3 2025.